Don Holly retweetledi

In a country where “access” is determined by what drugmakers say and not how many people afford and access the medications they need, the FDA’s determination around tirzepatide today isn’t surprising – but it should make you angry.
@elonmusk @RobertKennedyJr @realDonaldTrump @JDVance @VivekGRamaswamy
We should be prioritizing finding a solution to the obesity crisis in the US instead of helping anticompetitive pharmaceutical companies continue to price gouge the millions of Americans who are looking to take control of their healthcare.
Nothing would do more to improve the quality of millions of Americans’ lives than making GLP-1s truly affordable and accessible to everyone who needs them. Let's put America's health first, not big PhRMA's interests.
English
















